Next Day Disclosure Return

Earlier from Zylox-tonbridge Medical Technology Co., Ltd. Class H

• Zylox-Tonbridge Delivers Strong First-Half 2026 Results as International Revenue Surges 349%Aug 20
• Zylox-Tonbridge Recognized as Most Honored Company in Extel 2026 Asia Executive Team SurveyJun 8
• Zylox-Tonbridge Reports 2025 Annual Results with Revenue Exceeding RMB 1.06 Billion and Net Profit Up 143.7% Year-over-YearMar 17
• Zylox-Tonbridge to Acquire Equity Interest in A European Medical Device Company to Accelerate Expansion in the Global MedTech MarketJan 16